158 related articles for article (PubMed ID: 34231037)
1. Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores.
Ismail MF; Hirschfield GM; Hansen B; Tafur M; Elbanna KY; Goldfinger MH; Ridgway GR; Jhaveri KS
Eur Radiol; 2022 Jan; 32(1):67-77. PubMed ID: 34231037
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography.
Tafur M; Cheung A; Menezes RJ; Feld J; Janssen H; Hirschfield GM; Jhaveri KS
Eur Radiol; 2020 Jul; 30(7):3735-3747. PubMed ID: 32130494
[TBL] [Abstract][Full Text] [Related]
3. MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes.
Bookwalter CA; Venkatesh SK; Eaton JE; Smyrk TD; Ehman RL
Abdom Radiol (NY); 2018 Dec; 43(12):3260-3270. PubMed ID: 29626258
[TBL] [Abstract][Full Text] [Related]
4. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
5. The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.
Jhaveri KS; Hosseini-Nik H; Sadoughi N; Janssen H; Feld JJ; Fischer S; Menezes R; Cheung AC
Eur Radiol; 2019 Feb; 29(2):1039-1047. PubMed ID: 30051141
[TBL] [Abstract][Full Text] [Related]
6. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
7. Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
Gilligan LA; Trout AT; Lam S; Singh R; Tkach JA; Serai SD; Miethke AG; Dillman JR
Abdom Radiol (NY); 2020 Jan; 45(1):168-176. PubMed ID: 31422438
[TBL] [Abstract][Full Text] [Related]
8. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.
Selvaraj EA; Ba-Ssalamah A; Poetter-Lang S; Ridgway GR; Brady JM; Collier J; Culver EL; Bailey A; Pavlides M
Hepatol Commun; 2022 Apr; 6(4):795-808. PubMed ID: 34802195
[TBL] [Abstract][Full Text] [Related]
9. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.
Cristoferi L; Porta M; Bernasconi DP; Leonardi F; Gerussi A; Mulinacci G; Palermo A; Gallo C; Scaravaglio M; Stucchi E; Maino C; Ippolito D; D'Amato D; Ferreira C; Nardi A; Banerjee R; Valsecchi MG; Antolini L; Corso R; Sironi S; Fagiuoli S; Invernizzi P; Carbone M
Dig Liver Dis; 2023 Mar; 55(3):373-380. PubMed ID: 36357293
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in quantitative magnetic resonance imaging metrics in children and young adults with autoimmune liver disease.
Mahalingam N; Trout AT; Zhang B; Castro-Rojas C; Miethke AG; Dillman JR
Abdom Radiol (NY); 2023 Jun; 48(6):1933-1944. PubMed ID: 36799997
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease.
McCrary J; Trout AT; Mahalingam N; Singh R; Rojas CC; Miethke AG; Dillman JR
AJR Am J Roentgenol; 2022 Jul; 219(1):142-150. PubMed ID: 35080454
[No Abstract] [Full Text] [Related]
13. A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis.
Vuppalanchi R; Are V; Telford A; Young L; Mouchti S; Ferreira C; Kettler C; Gromski M; Akisik F; Chalasani N
JHEP Rep; 2023 Oct; 5(10):100834. PubMed ID: 37663118
[TBL] [Abstract][Full Text] [Related]
14. Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study.
Trivedi PJ; Arndtz K; Abbas N; Telford A; Young L; Banerjee R; Eddowes P; Jhaveri KS; Hirschfield GM
Aliment Pharmacol Ther; 2024 Jun; 59(11):1366-1375. PubMed ID: 38571284
[TBL] [Abstract][Full Text] [Related]
15. The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
Cazzagon N; Lemoinne S; El Mouhadi S; Trivedi PJ; Gaouar F; Kemgang A; Ben Belkacem K; Floreani A; Hirschfield G; Chretien Y; Housset C; Motta R; Russo FP; Chazouillères O; Arrivé L; Corpechot C
Am J Gastroenterol; 2019 Dec; 114(12):1878-1885. PubMed ID: 31738286
[TBL] [Abstract][Full Text] [Related]
16. Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis.
Mazhar A; Russo MW
Aliment Pharmacol Ther; 2021 Apr; 53(7):774-783. PubMed ID: 33608929
[TBL] [Abstract][Full Text] [Related]
17. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
18. Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis.
Petrovic BD; Nikolaidis P; Hammond NA; Martin JA; Petrovic PV; Desai PM; Miller FH
Dig Dis Sci; 2007 Dec; 52(12):3499-506. PubMed ID: 17410447
[TBL] [Abstract][Full Text] [Related]
19. Adult Primary Sclerosing Cholangitis (PSC) subjects have worse biliary disease at diagnosis compared to pediatric PSC subjects.
Kulkarni S; Bhimaniya S; Chi L; Tica S; Alghamdi S; Stoll J; Caudill K; Fleckenstein J
Clin Imaging; 2023 May; 97():7-13. PubMed ID: 36868034
[TBL] [Abstract][Full Text] [Related]
20. MR elastography in primary sclerosing cholangitis: a pictorial review.
Welle CL; Navin PJ; Olson MC; Hoodeshenas S; Torbenson MS; Venkatesh SK
Abdom Radiol (NY); 2023 Jan; 48(1):63-78. PubMed ID: 35567617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
